ClinicalTrials.gg
CompletedNCT03718416PATH for PWSUpdated Feb 29, 2024

Natural History Study of Serious Medical Events in PWS

An observational study in Prader-Willi Syndrome, sponsored by Foundation for Prader-Willi Research. Completed at 1 site in United States. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2024-02-29.

Sponsored by Foundation for Prader-Willi Research · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
700
Ages
5 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 69 studies in Prader-Willi Syndrome with a site in United States — 9 open to participants now, 14 under way, 3 of them phase 3. Prader-Willi Syndrome · United States.

Enrollment
4th of 11
700 · median 200
Started
2018
with 9 others
Observational
11 of 69
1 open now
Registered
36th of 69
by date

Among the 69 studies in Prader-Willi Syndrome with a site in United States, this one is the 4th largest by enrollment of the 11 observational ones that give a count, is one of 10 that started in 2018, is one of 11 observational ones, and was the 36th registered.

Prader-Willi Syndrome

144 studies on the registry are indexed under Prader-Willi Syndrome; 23 are open to participants now.

Browse Prader-Willi Syndrome studies →

Open to participants now

9 of the 69 studies in Prader-Willi Syndrome with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 16 Prader-Willi Syndrome studies recruiting now, 7 (44%) set no upper age limit and 9 (56%) stop at 75 or younger; 11 take children under 18; 1 takes healthy volunteers.

This study: 5 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Prader-Willi Syndrome with a site in United States, or all of them as a file.
02

Study summary

PATH for PWS is a study to help researchers better understand serious medical events in PWS over a 4-year period, as well as evaluate how PWS-related behaviors change over time. The data from this study is intended to inform the development and clinical trial design of potential new treatments.

Read the detailed description

Every 6 months, participants or their caregivers will be asked to update online surveys about medical problems and serious medical events, as well as provide information about conditions and behaviors often associated with PWS such as hyperphagia. Because this is an observational study, no study drug will be provided and no visits to a doctor or clinic are required.

03

Conditions studied

  • Prader-Willi Syndrome

Browse trials for

Keywords

  • observational
  • non-interventional
  • Prader-Willi syndrome
  • PWS
04

Who can participate

Ages eligible
5 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants with PWS who are at least 5 years old and live in the United States, Canada, Australia, or New Zealand

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants must meet all of the following criteria:

  • Confirmed diagnosis of PWS
  • At least 5 years of age
  • Live in the United States, Canada, Australia, or New Zealand
  • Must be enrolled or willing to enroll in the Global PWS Registry (https://pwsregistry.org)

Participants or their caregiver must also meet all of the following criteria:

  • Have access to the internet to complete online surveys at least every 6 months
  • Agree to receive reminders to complete online surveys
  • Allow the staff to ask questions about survey responses if more information is needed and to enter data into the surveys

Exclusion criteria

Exclusion Criteria:

Participants or their caregiver meeting any of the following criteria will be excluded:

  • Is not able to read and understand English
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
700 participants (actual)
Target follow-up
4 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Evaluate the incidence of serious medical events

    Serious medical events are those that result in death, are life-threatening, require hospitalization or an emergency room visit, or are medically significant

    Time frame: Up to 4 years

Secondary outcomes

  1. Evaluate the incidence of non-serious thrombotic events

    Thrombotic events include blood clots in a blood vessel, such as an artery or vein

    Time frame: Up to 4 years

  2. Analyze D-dimer concentrations in a subset of participants who agree to provide a blood sample

    D-dimer is a protein in the blood that is present when a blood clot is forming or has formed

    Time frame: Up to 4 years

  3. Evaluate prescription medication use associated with serious medical events and thrombotic events

    Time frame: Up to 4 years

  4. Evaluate the change in weight

    Time frame: Up to 4 years

  5. Evaluate the change in height

    Time frame: Up to 4 years

  6. Evaluate the change in height-adjusted weight

    Time frame: Up to 4 years

  7. Evaluate PWS complexity using an online survey

    Time frame: Up to 4 years

  8. Evaluate the pattern of hyperphagia behaviors using an online survey

    Hyperphagia means the intense, constant hunger that often occurs in individuals with PWS

    Time frame: Up to 4 years

  9. Evaluate hyperphagia management using an online survey

    Time frame: Up to 4 years

  10. Evaluate food-related behaviors using an online survey

    Time frame: Up to 4 years

  11. Analyze medical information to evaluate the natural history of PWS

    Medical information will be from birth to before enrolling in the study

    Time frame: Up to 4 years

07

Study locations

1 site
  • Foundation for Prader-Willi Research (FPWR)
    Walnut, California 91789, United States
08

References and documents

Individual participant data

Plan to share: Yes — FPWR allows for registry use by request and releases de-identified data to the public.

Access criteria: Data access will be governed by the Global PWS Registry advisory board.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2018 to primary completion in Jan 2024, 64 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 12, 2018
First posted
Oct 24, 2018
StartActual
Sep 28, 2018
Primary completionActual
Jan 31, 2024
CompletionActual
Jan 31, 2024
Last update
Feb 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03718416
Lead sponsor
Foundation for Prader-Willi Research
Collaborators
Prader-Willi Syndrome Association USA, Foundation for Prader-Willi Research Canada, Prader-Willi Research Foundation Australia, Prader-Willi Syndrome Association
Responsible party
Sponsor
First posted
Oct 24, 2018
Start date
Sep 28, 2018
Primary completion
Jan 31, 2024
Completion
Jan 31, 2024
Last update
Feb 29, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion